- Home
- CURR vs VTGN Comparison
CURR vs VTGN Comparison
Compare CURR & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CURR
- VTGN
- Stock Information
- Founded
- CURR 2013
- VTGN 1998
- Country
- CURR Singapore
- VTGN United States
- Employees
- CURR N/A
- VTGN N/A
- Industry
- CURR Business Services
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- CURR Consumer Discretionary
- VTGN Health Care
- Exchange
- CURR Nasdaq
- VTGN Nasdaq
- Market Cap
- CURR 74.0M
- VTGN 62.9M
- IPO Year
- CURR N/A
- VTGN N/A
- Fundamental
- Price
- CURR $0.60
- VTGN $2.39
- Analyst Decision
- CURR Strong Buy
- VTGN
- Analyst Count
- CURR 1
- VTGN 0
- Target Price
- CURR $3.50
- VTGN N/A
- AVG Volume (30 Days)
- CURR 2.0M
- VTGN 150.5K
- Earning Date
- CURR 05-20-2025
- VTGN 06-10-2025
- Dividend Yield
- CURR N/A
- VTGN N/A
- EPS Growth
- CURR N/A
- VTGN N/A
- EPS
- CURR N/A
- VTGN N/A
- Revenue
- CURR $43,386,858.00
- VTGN $698,000.00
- Revenue This Year
- CURR N/A
- VTGN N/A
- Revenue Next Year
- CURR $17.98
- VTGN N/A
- P/E Ratio
- CURR N/A
- VTGN N/A
- Revenue Growth
- CURR N/A
- VTGN N/A
- 52 Week Low
- CURR $0.44
- VTGN $1.90
- 52 Week High
- CURR $7.08
- VTGN $4.21
- Technical
- Relative Strength Index (RSI)
- CURR N/A
- VTGN 49.27
- Support Level
- CURR N/A
- VTGN $2.35
- Resistance Level
- CURR N/A
- VTGN $2.63
- Average True Range (ATR)
- CURR 0.00
- VTGN 0.15
- MACD
- CURR 0.00
- VTGN 0.01
- Stochastic Oscillator
- CURR 0.00
- VTGN 41.30
About CURR Currenc Group Inc. Ordinary Shares
Currenc Group Inc is a fintech banking platform for e-wallets, financial institutions and merchants world-wide, delivering frictionless interoperable real-time fund transfers and instant messaging.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.